Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Malignant Mesenchymal Tumor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Temporarily pausedNCT03316573
What this trial is testing

Pembrolizumab in Neoplasms or Lymphomas

Who this might be right for
LymphomaHistiocytic SarcomaFollicular Dendritic Cell Sarcoma+1 more
Dana-Farber Cancer Institute 18
Testing effectiveness (Phase 2)Study completedNCT02611024
What this trial is testing

Pharmacokinetic Study of Lurbinectedin in Combination With Irinotecan in Patients With Selected Solid Tumors

Who this might be right for
Advanced Solid TumorsGlioblastomaSoft Tissue Sarcoma (Excluding GIST)+9 more
PharmaMar 316
Not applicableNot Yet RecruitingNCT07492823
What this trial is testing

Clinical Applicability of Liquid Biopsy in Chondrosarcoma

Who this might be right for
Chondrosarcoma of the Bone
Medical University of Graz 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT03778996
What this trial is testing

SM-88 Maintenance Therapy for Advanced Ewing's Sarcoma and as Salvage Therapy for Sarcoma

Who this might be right for
Sarcoma, EwingSarcoma
Sarcoma Oncology Research Center, LLC 31
Not applicableActive Not RecruitingNCT06452446
What this trial is testing

Telehealth-based Symptom Management for Veterans Treated With Selinexor

Who this might be right for
Multiple MyelomaLarge-cell Lymphoma
Durham VA Medical Center 20
Not applicableStudy completedNCT04377360
What this trial is testing

Feasibility Trial of Diffusing Alpha-emitter Radiation Therapy (DaRT) for Malignant Skin & Superficial Soft Tissue Tumors

Who this might be right for
Malignant Skin TumorSoft Tissue Tumor, Malignant
Alpha Tau Medical LTD. 10
Not applicableEnded earlyNCT00896961
What this trial is testing

EF5 to Evaluate Tumor Hypoxia in Patients With High-Grade Soft Tissue Sarcoma or Mouth Cancer

Who this might be right for
Stage I Adult Soft Tissue SarcomaStage I Squamous Cell Carcinoma of the Lip and Oral CavityStage II Adult Soft Tissue Sarcoma+3 more
National Cancer Institute (NCI) 120
Testing effectiveness (Phase 2)Looking for participantsNCT05950594
What this trial is testing

IVIM & OLINK in Sarcoma

Who this might be right for
Soft Tissue Sarcoma
University Health Network, Toronto 145
Testing effectiveness (Phase 2)Study completedNCT01027910
What this trial is testing

PCI-24781 in Combination With Doxorubicin to Treat Sarcoma

Who this might be right for
Sarcoma
Massachusetts General Hospital 20
Not applicableStudy completedNCT02069769
What this trial is testing

Ensuring Communication in Hospice by Oncology Study (ECHO)

Who this might be right for
Ovarian CancerCervical CancerUterine Cancer+3 more
Massachusetts General Hospital 30
Early research (Phase 1)Study completedNCT01522820
What this trial is testing

Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors

Who this might be right for
Anaplastic AstrocytomaAnaplastic OligoastrocytomaAnaplastic Oligodendroglioma+62 more
Roswell Park Cancer Institute 18
Testing effectiveness (Phase 2)Study completedNCT00002673
What this trial is testing

Immunotherapy in Treating Patients Who Are Undergoing Bone Marrow or Peripheral Stem Cell Transplantation

Who this might be right for
Cancer
Fred Hutchinson Cancer Center 30
Testing effectiveness (Phase 2)Study completedNCT00003745
What this trial is testing

Chemotherapy in Treating Children With Recurrent or Refractory Sarcomas

Who this might be right for
Sarcoma
National Cancer Institute (NCI) 125
Testing effectiveness (Phase 2)Ended earlyNCT01621477
What this trial is testing

T-Cell Replete Haploidentical Donor Hematopoietic Stem Cell Plus Natural Killer (NK) Cell Transplantation in Patients With Hematologic Malignancies Relapsed or Refractory Despite Previous Allogeneic Transplant

Who this might be right for
Acute Lymphoblastic LeukemiaAcute Myelocytic LeukemiaChronic Myelocytic Leukemia+4 more
St. Jude Children's Research Hospital 34
Early research (Phase 1)WithdrawnNCT02839694
What this trial is testing

Adjuvant Oral Decitabine and Tetrahydrouridine With or Without Celecoxib in People Undergoing Pulmonary Metastasectomy

Who this might be right for
Neoplasm MetastasisSarcomaNeoplasms, Germ Cell and Embryonal+1 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Ended earlyNCT00642941
What this trial is testing

R1507 in Participants With Recurrent or Refractory Sarcoma

Who this might be right for
Sarcoma
Hoffmann-La Roche 317
Not applicableNo Longer AvailableNCT02570412
What this trial is testing

Compassionate Use of Aldoxorubicin in Sarcoma Patients Chemotherapy

Who this might be right for
Sarcoma
CytRx
Early research (Phase 1)Ended earlyNCT02784795
What this trial is testing

LY3039478 in Participants With Advanced or Metastatic Solid Tumors

Who this might be right for
Solid TumorBreast CancerColon Cancer+2 more
Eli Lilly and Company 94
Not applicableUnknownNCT03680430
What this trial is testing

Evaluation of Adaptive Radiation Therapy in Pre-operative or Exclusive Radiation Therapy for Limb Soft Tissues Sarcomas

Who this might be right for
Sarcoma, Soft Tissue
Institut Paoli-Calmettes 61
Early research (Phase 1)Study completedNCT01992341
What this trial is testing

AMG 386 Drug-Drug Interaction Study With Paclitaxel

Who this might be right for
Advanced Solid Tumors
Amgen 35
Next Page